{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:55:22Z","timestamp":1770836122296,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/bmt.2017.64","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T14:23:26Z","timestamp":1493043806000},"page":"1065-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patient"],"prefix":"10.1038","volume":"52","author":[{"given":"J","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"BFbmt201764_CR1","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3324\/haematol.2016.144311","volume":"101","author":"N G\u00f6kbuget","year":"2016","unstructured":"G\u00f6kbuget N, Dombret H, Ribera JM, Fielding AK, Advani A, Bassan R et al. International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed\/refractory acute lymphoblastic leukemia. Haematologica 2016; 101: 1524\u20131533.","journal-title":"Haematologica"},{"key":"BFbmt201764_CR2","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1182\/blood-2014-09-599894","volume":"125","author":"N Dh\u00e9din","year":"2015","unstructured":"Dh\u00e9din N, Huynh A, Maury S, Tabrizi R, Beldjord K, Asnafi V et al. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood 2015; 125: 2486\u20132496.","journal-title":"Blood"},{"key":"BFbmt201764_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.bbmt.2013.04.014","volume":"19","author":"LM Poon","year":"2013","unstructured":"Poon LM, Hamdi A, Saliba R, Rondon G, Ledesma C, Kendrick M et al. Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 1059\u20131064.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201764_CR4","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.bbmt.2014.08.023","volume":"20","author":"XD Mo","year":"2014","unstructured":"Mo XD, Kong J, Zhao T, Xu LP, Zhang XH, Liu DH et al. Extramedullary relapse of acute leukemia after haploidentical hematopoietic stem cell transplantation: incidence, risk factors, treatment, and clinical outcomes. Biol Blood Marrow Transplant 2014; 20: 2023\u20132028.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201764_CR5","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1182\/blood-2012-02-265884","volume":"120","author":"F Locatelli","year":"2012","unstructured":"Locatelli F, Schrappe M, Bernardo ME, Rutella S . How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012; 120: 2807\u20132816.","journal-title":"Blood"},{"key":"BFbmt201764_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/0019-509X.63002","volume":"47","author":"KP Kulkarni","year":"2010","unstructured":"Kulkarni KP, Marwaha RK, Trehan A, Bansal D . Testicular relapse in childhood acute lymphoblastic leukemia: the challenges and lessons. Indian J Cancer 2010; 47: 134\u2013138.","journal-title":"Indian J Cancer"},{"key":"BFbmt201764_CR7","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1172\/JCI86721","volume":"126","author":"P Kebriaei","year":"2016","unstructured":"Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S et al. Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells. J Clin Invest 2016; 126: 3363\u20133376.","journal-title":"J Clin Invest"},{"key":"BFbmt201764_CR8","doi-asserted-by":"crossref","unstructured":"Hu Y, Wu Z, Luo Y, Shi J, Yu J, Pu C et al. Potent anti-leukemia activities of chimeric antigen receptor modified T cells against CD19 in Chinese patients with relapsed\/refractory acute lymphocytic leukemia. Clin Cancer Res, (e-pub ahead of print 30 December 2016; doi:10.1158\/1078-0432.CCR-16-1799).","DOI":"10.1158\/1078-0432.CCR-16-1799"},{"key":"BFbmt201764_CR9","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","volume":"127","author":"JH Park","year":"2016","unstructured":"Park JH, Geyer MB, Brentjens RJ . CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood 2016; 127: 3312\u20133320.","journal-title":"Blood"},{"key":"BFbmt201764_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2174\/157339912803529896","volume":"8","author":"MG Alves","year":"2012","unstructured":"Alves MG, Oliveira PF, Socorro S, Moreira PI . Impact of diabetes in blood-testis and blood-brain barriers: resemblances and differences. Curr Diabetes Rev 2012; 8: 401\u2013412.","journal-title":"Curr Diabetes Rev"},{"key":"BFbmt201764_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-016-0299-5","volume":"9","author":"Y Hu","year":"2016","unstructured":"Hu Y, Sun J, Wu Z, Yu J, Cui Q, Pu C et al. Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. J Hematol Oncol 2016; 9: 70.","journal-title":"J Hematol Oncol"},{"key":"BFbmt201764_CR12","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1182\/blood-2014-04-571570","volume":"124","author":"Y Luo","year":"2014","unstructured":"Luo Y, Xiao H, Lai X, Shi J, Tan Y, He J et al. T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT. Blood 2014; 124: 2735\u20132743.","journal-title":"Blood"},{"key":"BFbmt201764_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/bmt.2009.138","volume":"45","author":"VA Bhadri","year":"2010","unstructured":"Bhadri VA, McGregor MR, Venn NC, Hackenberg N, Russell SJ, Norris MD et al. Isolated testicular relapse after allo-SCT in boys with ALL: outcome without second transplant. Bone Marrow Transplant 2010; 45: 397\u2013399.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201764_CR14","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1097\/MPH.0b013e318271c470","volume":"35","author":"AV Garcia","year":"2013","unstructured":"Garcia AV, Alobeid B, Traina JM, Chen SS, Weiner MA, Middlesworth W . Isolated primary testicular B lymphoblastic lymphoma: an unusual presentation. J Pediatr Hematol Oncol 2013; 35: e88\u2013e90.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt201764_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1399-3046.2008.01023.x","volume":"13","author":"Y Kodama","year":"2009","unstructured":"Kodama Y, Okamoto Y, Ijichi O, Shinkoda Y, Nishikawa T, Tanabe T et al. Continued complete remission without systemic therapy for isolated testicular relapse after bone marrow transplantation in a boy with acute lymphoblastic leukemia. Pediatr Transplant 2009; 13: 769\u2013772.","journal-title":"Pediatr Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201764","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.64","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:04:43Z","timestamp":1648065883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFbmt201764"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.64","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"24 April 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}